Perrigo Company (NYSE:PRGO)‘s stock had its “sell” rating reaffirmed by equities research analysts at Royal Bank Of Canada in a research report issued to clients and investors on Wednesday. They currently have a $64.00 price target on the stock. Royal Bank Of Canada’s target price would suggest a potential downside of 28.10% from the stock’s current price.

A number of other brokerages also recently commented on PRGO. Canaccord Genuity reaffirmed a “buy” rating and set a $100.00 target price (up from $88.00) on shares of Perrigo in a research note on Wednesday. Cantor Fitzgerald lifted their target price on shares of Perrigo from $93.00 to $107.00 and gave the stock an “overweight” rating in a research note on Tuesday. BidaskClub raised shares of Perrigo from a “strong sell” rating to a “sell” rating in a research note on Saturday. Stifel Nicolaus reaffirmed a “hold” rating on shares of Perrigo in a research note on Friday, August 11th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $71.00 target price (up from $69.00) on shares of Perrigo in a research note on Friday, August 11th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and eight have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $88.86.

Shares of Perrigo (NYSE PRGO) remained flat at $89.01 during trading on Wednesday. The stock had a trading volume of 1,547,948 shares. The company’s 50-day moving average price is $76.52 and its 200 day moving average price is $72.99. The company’s market capitalization is $12.69 billion. Perrigo has a 52 week low of $63.68 and a 52 week high of $99.14.

Perrigo (NYSE:PRGO) last issued its earnings results on Thursday, August 10th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.28. Perrigo had a negative net margin of 51.04% and a positive return on equity of 11.55%. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.18 billion. During the same period in the previous year, the firm earned $1.93 earnings per share. Perrigo’s quarterly revenue was down 7.7% compared to the same quarter last year. On average, equities analysts expect that Perrigo will post $4.58 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Perrigo Company (PRGO) Rating Reiterated by Royal Bank Of Canada” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/09/13/perrigo-company-prgo-rating-reiterated-by-royal-bank-of-canada.html.

In other Perrigo news, EVP Sharon Kochan sold 318 shares of the business’s stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $81.36, for a total transaction of $25,872.48. Following the completion of the transaction, the executive vice president now owns 10,231 shares in the company, valued at approximately $832,394.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Thomas Farrington sold 616 shares of the business’s stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $76.90, for a total transaction of $47,370.40. Following the transaction, the executive vice president now owns 2,724 shares of the company’s stock, valued at approximately $209,475.60. The disclosure for this sale can be found here. Insiders have sold a total of 3,299 shares of company stock valued at $259,604 in the last quarter. 6.90% of the stock is currently owned by company insiders.

Several institutional investors have recently modified their holdings of PRGO. BlackRock Inc. boosted its holdings in shares of Perrigo by 3,825.1% in the 1st quarter. BlackRock Inc. now owns 12,154,494 shares of the company’s stock valued at $806,936,000 after buying an additional 11,844,832 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Perrigo by 117.7% in the 2nd quarter. Franklin Resources Inc. now owns 8,109,742 shares of the company’s stock valued at $612,448,000 after buying an additional 4,383,903 shares in the last quarter. Aberdeen Asset Management PLC UK boosted its holdings in shares of Perrigo by 65.2% in the 1st quarter. Aberdeen Asset Management PLC UK now owns 3,028,619 shares of the company’s stock valued at $201,070,000 after buying an additional 1,195,526 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Perrigo by 4.5% in the 1st quarter. Vanguard Group Inc. now owns 14,574,768 shares of the company’s stock valued at $967,619,000 after buying an additional 633,343 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. boosted its holdings in shares of Perrigo by 50.9% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,846,993 shares of the company’s stock valued at $139,485,000 after buying an additional 623,370 shares in the last quarter. Institutional investors and hedge funds own 80.36% of the company’s stock.

About Perrigo

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Analyst Recommendations for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with MarketBeat.com's FREE daily email newsletter.